tirzepatide phase 2 Ozempic hits one receptor. hits two. Retatrutide hits three. That's the entire story. Retatrutide is a triple-agonist peptide currently in 3 trials. It activates three metabolic receptors simultaneously: GLP-1 (appetite + tirzepatide clinical trial enrollment A
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9




























